Invention Grant
- Patent Title: Substituted phenyloxazolidinones for antimicrobial therapy
-
Application No.: US15738503Application Date: 2016-07-15
-
Publication No.: US10550092B2Publication Date: 2020-02-04
- Inventor: Christopher B. Cooper , Haihong Huang , Dongfeng Zhang , Nader Fotouhi , Takushi Kaneko
- Applicant: The Global Alliance for TB Drug Development, Inc.
- Applicant Address: US NY New York
- Assignee: The Global Alliance for TB Drug Development, Inc.
- Current Assignee: The Global Alliance for TB Drug Development, Inc.
- Current Assignee Address: US NY New York
- International Application: PCT/US2016/042486 WO 20160715
- International Announcement: WO2017/015106 WO 20170126
- Main IPC: C07D263/20
- IPC: C07D263/20 ; C07D263/24 ; A61K31/422 ; A61K45/06 ; A61K31/554 ; C07D491/107 ; C07D495/10 ; C07D498/08 ; A61P31/06 ; A61K31/5386 ; C07D413/06 ; C07D413/12 ; C07D491/08 ; C07D495/08
Abstract:
The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.
Public/Granted literature
- US20180179168A1 SUBSTITUTED PHENYLOXAZOLIDINONES FOR ANTIMICROBIAL THERAPY Public/Granted day:2018-06-28
Information query
